Ainnocence

Ainnocence is pioneering the integration of AI and computational biology to accelerate drug discovery and development. Their research focuses on leveraging advanced machine learning models to predict the behavior of novel compounds, optimizing the design of new therapeutics. Ainnocence is developing next-generation therapies targeting complex diseases with high unmet medical needs in various therapeutic areas, including oncology, immunology, and neurology. By combining cutting-edge AI technology with biological insights, they aim to create safer, more effective treatments at a fraction of the traditional timeline.

Jobs: